The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
GIOTRIF as monotherapy is indicated for the treatment of: Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s); Locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy (see Pharmacology: Pharmacodynamics under Actions).
Sign Out
